Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Clinical trial NCT01767467 · COMPLETED
Trial details
- NCT number
- NCT01767467
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-01-07
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.